Effect of indacaterol on arterial blood gases in patients suffering from acute exacerbation of COPD

Respiratory Medicine

Volumn 108, Issue 2, 2014, Pages 307-313

  Rogliani, Paola ^a,b   Ora, Josuel ^b   Ciaprini, Chiara ^b   Senis, Lucia ^a,b   Stirpe, Emanuele ^a   Cazzola, Mario ^a,b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

Author keywords

Acute exacerbation; Arterial blood gases; COPD; Indacaterol

Indexed keywords

CEFTRIAXONE; CIPROFLOXACIN; CLARITHROMYCIN; INDACATEROL; PLACEBO; PREDNISOLONE;

ACUTE EXACERBATION CHRONIC OBSTRUCTIVE LUNG DISEASE; ADULT; AGED; ARTERIAL GAS; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE EXACERBATION; DRUG EFFECT; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HOSPITAL PATIENT; HUMAN; MALE; MIDDLE AGED; OXYGEN DESATURATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPIROMETRY; TENSION; VERY ELDERLY;

ACUTE EXACERBATION; ARTERIAL BLOOD GASES; COPD; INDACATEROL;

ACUTE DISEASE; ADMINISTRATION, INHALATION; ADRENERGIC BETA-2 RECEPTOR AGONISTS; AGED; AGED, 80 AND OVER; BLOOD GAS ANALYSIS; CARBON DIOXIDE; CROSS-OVER STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INDANS; MALE; MIDDLE AGED; OXYGEN; PARTIAL PRESSURE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUINOLONES; VITAL CAPACITY;

EID: 84893724878     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2013.10.022     Document Type: Article

References (26)

1. N. MacIntyre, and Y.C. Huang Acute exacerbations and respiratory failure in chronic obstructive pulmonary disease Proc Am Thorac Soc 5 2008 530 535
2. C.L. Emerman, and R.K. Cydulka Effect of different albuterol dosing regimens in the treatment of acute exacerbation of chronic obstructive pulmonary disease Ann Emerg Med 29 1997 474 478
3. M. Bernasconi, R. Brandolese, R. Poggi, E. Manzin, and A. Rossi Dose-response effects and time course of effects of inhaled fenoterol on respiratory mechanics and arterial oxygen tension in mechanically ventilated patients with chronic airflow obstruction Intensive Care Med 16 1990 108 114
4. J.P. Karpel, J. Pesin, D. Greenberg, and E. Gentry A comparison of the effects of ipratropium bromide and metaproterenol sulfate in acute exacerbations of COPD Chest 98 1990 835 839
5. 2 agonists as potential option in the treatment of acute exacerbations of COPD Pulm Pharmacol Ther 16 2003 197 201
6. M. Cazzola, C. Califano, F. Di Perna, M. D'Amato, C. Terzano, M.G. Matera, G. D'Amato, and S.A. Marsico Acute effects of higher than customary doses of salmeterol and salbutamol in patients with acute exacerbation of COPD Respir Med 96 2002 790 795
7. M. Cazzola, M. D'Amato, C. Califano, F. Di Perna, E. Calderaro, M.G. Matera, and G. D'Amato Formoterol as dry powder oral inhalation compared with salbutamol metered-dose inhaler in acute exacerbations of chronic obstructive pulmonary disease Clin Ther 24 2002 595 604
8. M. Cazzola, M.G. Matera, M. D'Amato, C. Califano, A. Sanduzzi, A. Vatrella, and G. D'Amato Bronchodilator response to formoterol turbuhaler in patients with COPD under regular treatment with formoterol turbuhaler Pulm Pharmacol Ther 16 2003 105 109
9. M. Cazzola, P. Santus, M.G. Matera, P. Carlucci, E. Belloli, F. Di Marco, and S. Centanni A single high dose of formoterol is as effective as the same dose administered in a cumulative manner in patients with acute exacerbation of COPD Respir Med 97 2003 458 462
10. M. Cazzola, A. Proietto, and M.G. Matera Indacaterol for chronic obstructive pulmonary disease (COPD) Drugs Today (Barc) 46 2010 139 150
11. M. Cazzola, F. Bardaro, and E. Stirpe The role of indacaterol for chronic obstructive pulmonary disease (COPD) J Thorac Dis 5 2013 559 566
12. B. Balint, H. Watz, C. Amos, R. Owen, M. Higgins, and B. Kramer Onset of action of indacaterol in patients with COPD: comparison with salbutamol and salmeterol-fluticasone Int J Chron Obstruct Pulmon Dis 5 2010 311 318
13. M. Cazzola, C.P. Page, L. Calzetta, and M.G. Matera Pharmacology and therapeutics of bronchodilators Pharmacol Rev 64 2012 450 504
14. M. Cazzola, P. Noschese, F. De Michele, G. D'Amato, and M.G. Matera Effect of formoterol/budesonide combination on arterial blood gases in patients with acute exacerbation of COPD Respir Med 100 2006 212 217
15. 2-agonists Respir Med 101 2007 1798 1803
16. J.A. Barbera, J. Roca, A. Ferrer, M.A. Félez, O. Díaz, N. Roger, and R. Rodriguez-Roisin Mechanisms of worsening gas exchange during acute exacerbations of chronic obstructive pulmonary disease Eur Respir J 10 1997 1285 1289
17. M. Cazzola, A. Segreti, E. Stirpe, E. Puxeddu, J. Ora, P. Rogliani, and M.G. Matera Effect of an additional dose of indacaterol in COPD patients under regular treatment with indacaterol Respir Med 107 2013 107 111
18. R. Rodriguez-Roisin Toward a consensus definition for COPD exacerbations Chest 117 5 Suppl 2 2000 398S 401S
19. M. Brzezinski, T. Luisetti, and M.J. London Radial artery cannulation: a comprehensive review of recent anatomic and physiologic investigations Anesth Analg 109 2009 1763 1781
20. C.V. Ringsted, K. Eliasen, J.B. Andersen, L. Heslet, and J. Qvist Ventilation-perfusion distributions and central hemodynamics in chronic obstructive pulmonary disease: effects of terbutaline administration Chest 96 1989 976 983
21. 2-agonists in chronic obstructive pulmonary disease severe exacerbations Am J Respir Crit Care Med 176 2007 350 355
22. A. Ferrer, J.A. Barbera, and R. Rodriguez-Roisin Gas exchange B.E. Celli, Pharmacotherapy in chronic obstructive pulmonary disease 2004 Marcel Dekker, Inc New York 95 117
23. A. Segreti, E. Fiori, L. Calzetta, M. Sabatini, V. Segreti, P. Rogliani, and M. Cazzola The effect of indacaterol during an acute exacerbation of COPD Pulm Pharmacol Ther 2013 [in press] http://dx.doi.org/10.1016/j.pupt.2013.03.020
24. 2-agonists safe in patients with acute exacerbations of COPD? Am J Respir Crit Care Med 176 2007 322
25. E.M. Amen, E.M. Becker, and H. Truebel Analysis of V/Q-matching - a safety biomarker in pulmonary drug development? Biomarkers 16 Suppl. 1 2011 S5 10
26. 2-agonist/inhaled corticosteroid combination Chest 141 2012 1134 1136